These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33069651)

  • 41. Predicting Outcomes After Percutaneous Coronary Intervention Using Relative Change in Fractional Flow Reserve.
    Kobayashi Y; Fearon WF
    JACC Cardiovasc Interv; 2018 Oct; 11(20):2110-2112. PubMed ID: 30336815
    [No Abstract]   [Full Text] [Related]  

  • 42. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention.
    Uretsky BF; Agarwal SK; Vallurupalli S; Al-Hawwas M; Hasan R; Miller K; Hakeem A
    J Am Heart Assoc; 2020 Feb; 9(3):e015073. PubMed ID: 32013707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
    Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
    Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Value of Pre- and Post-Stenting Fractional Flow Reserve for Predicting Mid-Term Stent Restenosis Following Percutaneous Coronary Intervention (PCI).
    Rai A; Bahremand M; Saidi MR; Jalili Z; Salehi N; Assareh M; Abarghoei GA; Kazerani H
    Glob J Health Sci; 2015 Dec; 8(7):240-44. PubMed ID: 26925913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between OCT-derived intrastent dimensions and fractional flow reserve measurements after coronary stent implantation and impact on clinical outcome.
    Reith S; Battermann S; Hellmich M; Marx N; Burgmaier M
    J Invasive Cardiol; 2015 May; 27(5):222-8. PubMed ID: 25929298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.
    Kitabata H; Kubo T; Shiono Y; Shimamura K; Ino Y; Tanimoto T; Hayashi Y; Komukai K; Sougawa H; Kimura K; Gohda M; Hashizume T; Obana M; Maeda K; Yamaguchi J; Akasaka T
    Trials; 2019 Jan; 20(1):84. PubMed ID: 30691507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three-Vessel Disease With the Routine Incorporation of Fractional Flow Reserve in Real Practice.
    Ahn JM; Yoon SH; Roh JH; Lee PH; Chang M; Park HW; Lee JY; Kang SJ; Park DW; Lee SW; Kim YH; Lee CW; Han S; Park SW; Park SJ
    Am J Cardiol; 2015 Oct; 116(8):1163-71. PubMed ID: 26318500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. To stent or not to stent. That is the fractional flow reserve.
    Brutkiewicz A; Tyczyński P; Kruk M; Kalińczuk Ł; Witkowski A
    Cardiol J; 2017; 24(5):576-577. PubMed ID: 29087537
    [No Abstract]   [Full Text] [Related]  

  • 49. Percutaneous coronary intervention driven by combined use of intracoronary anatomy and physiology: Towards a tailored therapy for coronary artery disease.
    Vizzari G; Di Giorgio A; Saporito F; Trio O; Versaci F; Andò G
    Int J Cardiol; 2015; 187():562-4. PubMed ID: 25863304
    [No Abstract]   [Full Text] [Related]  

  • 50. A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents.
    Han Y; Xu B; Fu G; Wang X; Xu K; Jin C; Tao L; Li L; Hou Y; Su X; Fang Q; Chen L; Liu H; Wang B; Yuan Z; Gao C; Zhou S; Sun Z; Zhao Y; Guan C; Stone GW;
    JACC Cardiovasc Interv; 2018 Feb; 11(3):260-272. PubMed ID: 29413240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes.
    Hakeem A; Uretsky BF
    Circulation; 2019 Jan; 139(5):694-706. PubMed ID: 30689413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel noninvasive technology for treatment planning using virtual coronary stenting and computed tomography-derived computed fractional flow reserve.
    Kim KH; Doh JH; Koo BK; Min JK; Erglis A; Yang HM; Park KW; Lee HY; Kang HJ; Kim YJ; Lee SY; Kim HS
    JACC Cardiovasc Interv; 2014 Jan; 7(1):72-8. PubMed ID: 24332418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease.
    Choi KH; Lee JM; Koo BK; Nam CW; Shin ES; Doh JH; Rhee TM; Hwang D; Park J; Zhang J; Kim KJ; Hu X; Wang J; Ye F; Chen S; Yang J; Chen J; Tanaka N; Yokoi H; Matsuo H; Takashima H; Shiono Y; Akasaka T
    JACC Cardiovasc Interv; 2018 Feb; 11(3):237-245. PubMed ID: 29361444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of drug eluting stents on cardiovascular events in patients with intermediate lesions and borderline fractional flow reserve.
    Lavi S; Rihal CS; Yang EH; Fassa AA; Elesber A; Lennon RJ; Mathew V; David HR; Lerman A
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):525-31. PubMed ID: 17896397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing Post-Percutaneous Coronary Intervention Physiology: Is Hyperemia Necessary?
    Jeremias A; Stone GW
    JACC Cardiovasc Interv; 2020 Aug; 13(16):1934-1936. PubMed ID: 32819482
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnostic accuracy of optical coherence tomography parameters in predicting in-stent hemodynamic severe coronary lesions: validation against fractional flow reserve.
    Belkacemi A; Stella PR; Ali DS; Novianti PW; Doevendans PA; van Belle E; Agostoni P
    Int J Cardiol; 2013 Oct; 168(4):4209-13. PubMed ID: 23953267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fractional flow reserve guided coronary revascularization in drug-eluting era in Thai patients with borderline multi-vessel coronary stenoses.
    Angkananard T; Wongpraparut N; Tresukosol D; Panchavinin P
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S25-32. PubMed ID: 21721425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome: An ILUMIEN I Substudy.
    Nakamura D; Wijns W; Price MJ; Jones MR; Barbato E; Akasaka T; Lee SW; Patel SM; Nishino S; Wang W; Gopinath A; Attizzani GF; Holmes D; Bezerra HG
    JACC Cardiovasc Interv; 2018 Aug; 11(15):1467-1478. PubMed ID: 30093052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in the outcomes of percutaneous coronary intervention with the routine incorporation of fractional flow reserve in real practice.
    Park SJ; Ahn JM; Park GM; Cho YR; Lee JY; Kim WJ; Han S; Kang SJ; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Park SW
    Eur Heart J; 2013 Nov; 34(43):3353-61. PubMed ID: 24092248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
    Vos NS; van der Schaaf RJ; Amoroso G; Herrman JP; Patterson MS; Slagboom T; Vink MA
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1213-21. PubMed ID: 26370515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.